It is involved in several processes, such as helping with the detoxification process, supporting the immune system and cardiovascular health, etc
This marks a significant step forward in obesity management, with clinical trials demonstrating ~21% weight loss at 72 weeks
The appetite suppression and caloric restriction achieved with GLP-1 treatment create an energy deficit that the body addresses by mobilizing stored fat throughout the body, including visceral depots
148(3): 43945 Cederblad G, Lindstedt S
A pH-sensitive microemulsion-filled gellan gum hydrogel encapsulated apigenin: characterization and in vitro release kinetics
Considering lower SIRT3 expression/activity and more pronounced inflammation in AT of obese patients, these findings have significant clinical implications